5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease – opportunities for novel therapeutics to reduce the problems of levodopa therapy
Dopamine agonists and neuroprotection in Parkinson's disease
Do dopamine agonists or levodopa modify Parkinson's disease progression?
The differential diagnosis of Parkinson's disease
Surgical therapy for Parkinson's disease
The basis for day and night-time control of symptoms of Parkinson's disease
Depression in Parkinson's disease
The therapeutic challenges in the older Parkinson's disease patient
Restless legs syndrome